AstraZeneca Plc plans to generate up to $1.5 billion in savings over the next three years by redeploying existing assets to invest in newer technologies and in the pipeline. The plan was announced on 30 October alongside the company’s third quarter results which showed a revenue increase of 7% to $16.2 billion for the three-month period. Operating profit was $4.4 billion, up by 22%. The company expects revenue for the year to increase by a mid-to-high single-digit percentage.
